Binding and GTPγS autoradiographic analysis of preproorphanin precursor peptide products at the ORL1 and opioid receptors

Journal of Chemical Neuroanatomy

Volumn 25, Issue 4, 2003, Pages 233-247

  Neal Jr , Charles R ^a,b   Owens, Constance E ^a   Taylor, Larry P ^a   Hoversten, Mary T ^a   Akil, Huda ^a   Watson Jr , Stanley J ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

GTP S autoradiography; Nociceptin; Opioid receptors; Orphanin FQ; Orphanin FQ II

Indexed keywords

BRAIN PEPTIDE; BRAIN PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MU OPIATE RECEPTOR; NALOXONE; NOCICEPTIN; NOCISTATIN; NARCOTIC ANTAGONIST; NOCICEPTIN RECEPTOR; OPIATE PEPTIDE; OPIATE RECEPTOR; PROTEIN PRECURSOR;

ANIMAL CELL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; AUTORADIOGRAPHY; BRAIN NUCLEUS; BRAIN REGION; BRAIN STEM; CARBOXY TERMINAL SEQUENCE; CEREBELLUM; CONTROLLED STUDY; CORRELATION ANALYSIS; FOREBRAIN; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; TISSUE SECTION; ANIMAL; BRAIN; CELL STRAIN COS1; COMPARATIVE STUDY; METABOLISM;

ANIMALS; AUTORADIOGRAPHY; BRAIN; COS CELLS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MALE; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID PEPTIDES; PROTEIN PRECURSORS; RATS; RECEPTORS, OPIOID;

EID: 0038094401     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-0618(03)00032-2     Document Type: Article

References (74)

1. Bunzow J.R., Saez C., Mortrud M., Bouvier C., Williams J.T., Low M., Grandy D.K. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett. 347:1994;284-288.
2. Butour J.L., Moisand C., Mazarguil H., Mollereau C., Meunier J.C. Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids. Eur. J. Pharmacol. 321:1997;97-103.
3. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:1987;2745-2752.
4. Chen Y., Fan Y., Liu J., Mestek A., Tian M., Kozak C.A., Yu L. Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett. 347:1994;279-283.
5. Cheng Y., Prusoff W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
6. Civelli O., Nothacker H.P., Reinscheid R. Reverse physiology: discovery of the novel neuropeptide, orphanin FQ/nociceptin. Crit. Rev. Neurobiol. 12:1998;163-176.
7. Danielson P.B., Dores R.M. Molecular evolution of the opioid/orphanin gene family. Gen. Comp. Endocrinol. 113:1999;169-186.
8. Danielson P.B., Hoversten M.T., Fitzpatrick M., Schreck C., Akil H., Dores R.M. Sturgeon orphanin, a molecular "fossil" that bridges the gap between the opioids and orphanin FQ/nociceptin. J. Biol. Chem. 276:2001;22114-22119.
9. Darland T., Heinricher M.M., Grandy D.K. Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci. 21:1998;215-221.
10. Dawson-Basoa M., Gintzler A.R. Nociceptin (orphanin FQ) abolishes gestational and ovarian sex steroid-induced antinociception and induces hyperalgesia. Brain Res. 750:1997;48-52.
11. 3H]nociceptin binding sites from telencephalic to mesencephalic regions of the mouse brain. Neurosci. Lett. 230:1997;33-36.
12. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H., Iwabe N., Miyata T., Houtani T., Sugimoto T. cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett. 343:1994;42-46.
13. Goldstein A., Naidu A. Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol. Pharmacol. 36:1989;265-272.
14. Grisel J.E., Mogil J.S., Belknap J.K., Grandy D.K. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. Neuroreport. 7:1996;2125-2129.
15. Harrison L.M., Grandy D.K. Opiate modulating properties of nociceptin/orphanin FQ. Peptides. 21:2000;151-172.
16. Heinricher M.M., McGaraughty S., Grandy D.K. Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla. J. Neurophysiol. 78:1997;3351-3358.
17. Henderson G., McKnight A.T. The orphan opioid receptor and its endogenous ligand - nociceptin/orphanin FQ. Trends Pharmacol. Sci. 18:1997;293-300.
18. Hiramatsu M., Inoue K. Effects of nocistatin on nociceptin-induced impairment of learning and memory in mice. Eur. J. Pharmacol. 367:1999;151-155.
19. Hiramatsu M., Inoue K. Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice. Br. J. Pharmacol. 127:1999;655-660.
20. Houtani T., Nishi M., Takeshima H., Nukada T., Sugimoto T. Structure and regional distribution of nociceptin/orphanin FQ precursor. Biochem. Biophys. Res. Commun. 219:1996;714-719.
21. Ikeda K., Watanabe M., Ichikawa T., Kobayashi T., Yano R., Kumanishi T. Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems. J. Comp. Neurol. 399:1998;139-151.
22. Jhamandas K.H., Sutak M., Henderson G. Antinociceptive and morphine modulatory actions of spinal orphanin FQ. Can. J. Physiol. Pharmacol. 76:1998;314-324.
23. Kest B., Hopkins E., Palmese C.A., Chen Z.P., Mogil J.S., Pintar J.E. Morphine tolerance and dependence in nociceptin/orphanin FQ transgenic knock-out mice. Neuroscience. 104:2001;217-222.
24. King M.A., Rossi G.C., Chang A.H., Williams L., Pasternak G.W. Spinal analgesic activity of orphanin FQ/nociceptin and its fragments. Neurosci. Lett. 223:1997;113-116.
25. Koster A., Montkowski A., Schulz S., Stube E.M., Knaudt K., Jenck F., Moreau J.L., Nothacker H.P., Civelli O., Reinscheid R.K. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc. Natl. Acad. Sci. USA. 96:1999;10444-10449.
26. Lachowicz J.E., Shen Y., Monsma F.J. Jr., Sibley D.R. Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J. Neurochem. 64:1995;34-40.
27. Ma L., Cheng Z.J., Fan G.H., Cai Y.C., Jiang L.Z., Pei G. Functional expression, activation and desensitization of opioid receptor-like receptor ORL1 in neuroblastoma×glioma NG108-15 hybrid cells. FEBS Lett. 403:1997;91-94.
28. Makman M.H., Lyman W.D., Dvorkin B. Presence and characterization of nociceptin (orphanin FQ) receptor binding in adult rat and human fetal hypothalamus. Brain Res. 762:1997;247-250.
29. Mamiya T., Noda Y., Nishi M., Takeshima H., Nabeshima T. Enhancement of spatial attention in nociceptin/orphanin FQ receptor-knockout mice. Brain Res. 783:1998;236-240.
30. Manabe T., Noda Y., Mamiya T., Katagiri H., Houtani T., Nishi M., Noda T., Takahashi T., Sugimoto T., Nabeshima T., Takeshima H. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature. 394:1998;577-581.
31. Marchese A., Docherty J.M., Nguyen T., Heiber M., Cheng R., Heng H.H., Tsui L.C., Shi X., George S.R., O'Dowd B.F. Cloning of human genes encoding novel G protein-coupled receptors. Genomics. 23:1994;609-618.
32. Meng F., Xie G.X., Thompson R.C., Mansour A., Goldstein A., Watson S.J. Jr., Akil H. Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc. Natl. Acad. Sci. USA. 90:1993;9954-9958.
33. Meng F., Ueda Y., Hoversten M.T., Taylor L.P., Reinscheid R.K., Monsma F.J. Jr., Watson S.J. Jr., Civelli O., Akil H. Creating a functional opioid alkaloid binding site in the orphanin FQ receptor through site-directed mutagenesis. Mol. Pharmacol. 53:1998;772-777.
34. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
35. Mogil J.S., Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev. 53:2001;381-415.
36. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337.
37. Mogil J.S., Grisel J.E., Zhangs G., Belknap J.K., Grandy D.K. Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ. Neurosci. Lett. 214:1996;131-134.
38. Mollereau C., Parmentier M., Mailleux P., Butour J.L., Moisand C., Chalon P., Caput D., Vassart G., Meunier J.C. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 341:1994;33-38.
39. Mollereau C., Simons M.J., Soularue P., Liners F., Vassart G., Meunier J.C., Parmentier M. Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc. Natl. Acad. Sci. USA. 93:1996;8666-8670.
40. Morgan M.M., Grisel J.E., Robbins C.S., Grandy D.K. Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ. Neuroreport. 8:1997;3431-3434.
41. Murphy W.J., Eizirik E., Johnson W.E., Zhang Y.P., Ryder O.A., O'Brien S.J. Molecular phylogenetics and the origins of placental mammals. Nature. 409:2001;614-618.
42. Nakano H., Minami T., Abe K., Arai T., Tokumura M., Ibii N., Okuda-Ashitaka E., Mori H., Ito S. Effect of intrathecal nocistatin on the formalin-induced pain in mice versus that of nociceptin/orphanin FQ. J. Pharmacol. Exp. Ther. 292:2000;331-336.
43. Neal C.R. Jr., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Akil H., Watson S.J. Jr. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J. Comp. Neurol. 412:1999;563-605.
44. Neal C.R. Jr., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Watson S.J. Jr. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406:1999;503-547.
45. Neal C.R. Jr., Akil H., Watson S.J. Jr. Expression of orphanin FQ and the opioid receptor-like (ORL1) receptor in the developing human and rat brain. J. Chem. Neuroanat. 22:2001;219-249.
46. Nicholson J.R., Paterson S.J., Menzies J.R., Corbett A.D., McKnight A.T. Pharmacological studies on the "orphan" opioid receptor in central and peripheral sites. Can. J. Physiol. Pharmacol. 76:1998;304-313.
47. Nishi M., Takeshima H., Fukuda K., Kato S., Mori K. cDNA cloning and pharmacological characterization of an opioid receptor with high affinities for kappa-subtype-selective ligands. FEBS Lett. 330:1993;77-80.
48. Nishi M., Houtani T., Noda Y., Mamiya T., Sato K., Doi T., Kuno J., Takeshima H., Nukada T., Nabeshima T., Yamashita T., Noda T., Sugimoto T. Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor. EMBO J. 16:1997;1858-1864.
49. Nothacker H.P., Reinscheid R.K., Mansour A., Henningsen R.A., Ardati A., Monsma F.J. Jr., Watson S.J. Jr., Civelli O. Primary structure and tissue distribution of the orphanin FQ precursor. Proc. Natl. Acad. Sci. USA. 93:1996;8677-8682.
50. Okuda-Ashitaka E., Minami T., Tachibana S., Yoshihara Y., Nishiuchi Y., Kimura T., Ito S. Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature. 392:1998;286-289.
51. Pampusch M.S., Serie J.R., Osinski M.A., Seybold V.S., Murtaugh M.P., Brown D.R. Expression of nociceptin/OFQ receptor and prepro-nociceptin/OFQ in lymphoid tissues. Peptides. 21:2000;1865-1870.
52. Pan Y.X., Xu J., Pasternak G.W. Cloning and expression of a cDNA encoding a mouse brain orphanin FQ/nociceptin precursor. Biochem. J. 315:(Part 1):1996;11-13.
53. Reinscheid R.K., Civelli O. The orphanin FQ/nociceptin knockout mouse: a behavioral model for stress responses. Neuropeptides. 36:2002;72-76.
54. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J. Jr., Civelli O. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794.
55. Reinscheid R.K., Ardati A., Monsma F.J. Jr., Civelli O. Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J. Biol. Chem. 271:1996;14163-14168.
56. Reinscheid R.K., Higelin J., Henningsen R.A., Monsma F.J. Jr., Civelli O. Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities. J. Biol. Chem. 273:1998;1490-1495.
57. Rossi G.C., Leventhal L., Bolan E., Pasternak G.W. Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J. Pharmacol. Exp. Ther. 282:1997;858-865.
58. Rossi G.C., Mathis J.P., Pasternak G.W. Analgesic activity of orphanin FQ2, murine prepro-orphanin FQ141-157 in mice. Neuroreport. 9:1998;1165-1168.
59. Rossi G.C., Pellegrino M., Shane R., Abbadie C.A., Dustman J., Jimenez C., Bodnar R.J., Pasternak G.W., Allen R.G. Characterization of rat prepro-orphanin FQ/nociceptin(154-181): nociceptive processing in supraspinal sites. J. Pharmacol. Exp. Ther. 300:2002;257-264.
60. 35S]GTPgammaS binding in comparison with opioid agonist-stimulated ones in brain regions of the mice. Neurosci. Lett. 237:1997;113-116.
61. 35S]guanylyl-5′-O-(gamma-thio)-triphosphate binding in guinea pig brain. J. Comp. Neurol. 386:1997;562-572.
62. 35S]GTP gamma S binding in rat brain. Neuroreport. 7:1996;729-733.
63. Thompson R.C., Mansour A., Akil H., Watson S.J. Jr. Cloning and pharmacological characterization of a rat mu opioid receptor. Neuron. 11:1993;903-913.
64. Tian J.H., Xu W., Fang Y., Han J.S. Antagonistic effect of orphanin FQ on morphine analgesia in rat brain. Sheng Li Xue Bao. 49:1997;333-338.
65. Tian J.H., Xu W., Fang Y., Mogil J.S., Grisel J.E., Grandy D.K., Han J.S. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br. J. Pharmacol. 120:1997;676-680.
66. Ueda H., Yamaguchi T., Tokuyama S., Inoue M., Nishi M., Takeshima H. Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene. Neurosci. Lett. 237:1997;136-138.
67. Wang J.B., Johnson P.S., Imai Y., Persico A.M., Ozenberger B.A., Eppler C.M., Uhl G.R. cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett. 348:1994;75-79.
68. Wick M.J., Minnerath S.R., Lin X., Elde R., Law P.Y., Loh H.H. Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned mu, delta, and kappa opioid receptors. Brain Res. Mol. Brain Res. 27:1994;37-44.
69. Wu Y.L., Pu L., Ling K., Zhao J., Cheng Z.J., Ma L., Pei G. Molecular characterization and functional expression of opioid receptor-like1 receptor. Cell Res. 7:1997;69-77.
70. Xu X.J., Hao J.X., Wiesenfeld-Hallin Z. Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. Neuroreport. 7:1996;2092-2094.
71. Xu I.S., Hashemi M., Calo G., Regoli D., Wiesenfeld-Hallin Z., Xu X.J. Effects of intrathecal nocistatin on the flexor reflex and its interaction with orphanin FQ nociceptin. Neuroreport. 10:1999;3681-3684.
72. Yamamoto T., Sakashita Y. Effect of nocistatin and its interaction with nociceptin/orphanin FQ on the rat formalin test. Neurosci. Lett. 262:1999;179-182.
73. Yamamoto T., Nozaki-Taguchi N., Kimura S. Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, in the rat formalin test. Neuroscience. 81:1997;249-254.
74. Zhao C.S., Li B.S., Zhao G.Y., Liu H.X., Luo F., Wang Y., Tian J.H., Chang J.K., Han J.S. Nocistatin reverses the effect of orphanin FQ/nociceptin in antagonizing morphine analgesia. Neuroreport. 10:1999;297-299.